Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Release Therapeutics SA

History from 9 Feb 2016

UID
CHE-112.690.021
Legal form
AG
Canton
GE
Founded
not in the record
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 1.1M
279k558k836k1.1M4 Sep 2018 · CHF 368k22 Aug 2019 · CHF 386k17 Oct 2019 · CHF 401k29 Sep 2023 · CHF 664k18 Jun 2024 · CHF 1M19 Sep 2025 · CHF 1.1M20182019202020212022202320242025
  • shares
  • all shares

Record

  1. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    348’798.30 → 368’329.30
    Shares
    3’487’983 → 3’683’293
    New shares, % of post-step shares
    5.3% (195’310 new)

    Augmentation autorisée du capital-actions, fondée sur la décision d'autorisation du 14.06.2018, porté de CHF 348'798, 30 à CHF 368'329, 30 par l'émission de 195'310 actions de CHF 0.10, nominatives. Capital-actions: CHF 368'329, 30, entièrement libéré, divisé en 3'683'293 actions de CHF 0.10, nominatives. Suppression de la clause statutaire relative à l'augmentation autorisée du capital fondée sur la décision d'autorisation du 14.06.2018, le montant de l'augmentation ayant été atteint.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-0004448890 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    368’329.30 → 386’416.50
    Shares
    3’503’293 → 3’684’165
    New shares, % of post-step shares
    4.9% (180’872 new)

    Augmentation autorisée du capital-actions, fondée sur la décision d'autorisation du 11.07.2019, porté de CHF 368'329, 30 à CHF 386'416, 50 par l'émission de 180'872 actions de CHF 0.10, nominatives. Capital-actions: CHF 386'416, 50, entièrement libéré, divisé en 3'684'165 actions de CHF 0.10, nominatives.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1004701001 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    386’416.50 → 400’881.30
    Shares
    3’864’165 → 4’008’813
    New shares, % of post-step shares
    3.6% (144’648 new)

    Augmentation autorisée du capital-actions, fondée sur la décision d'autorisation du 11.07.2019, porté de CHF 386'416, 50 à CHF 400'881, 30, par l'émission de 144'648 actions de CHF 0.10, nominatives entièrement libérées. Capital-actions: CHF 400'881, 30, entièrement libéré, divisé en 4'008'813 actions de CHF 0.10, nominatives. Suppression de la clause statutaire relative à l'augmentation autorisée du capital-actions, fondée sur la décision d'autorisation du 11.07.2019, le montant de l'augmentation ayant été atteint.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1004740134 ↗
  4. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    400’881.30 → 664’098.40
    Shares
    5’330’444 → 6’640’984
    New shares, % of post-step shares
    19.7% (1’310’540 new)

    Capital-actions: CHF 664'098, 40, entièrement libéré, divisé en 6'640'984 actions de CHF 0.10, nominatives.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005849266 ↗
  5. Name changed

    MaxiVAX SA → Release Therapeutics SA

    SHAB HR02-1005849266 ↗
  6. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    664’098.40 → 1’036’041.40
    Shares
    6’640’984 → 10’360’414
    New shares, % of post-step shares
    35.9% (3’719’430 new)

    Capital-actions: CHF 1'036'041, 4, entièrement libéré, divisé en 10'360'414 actions de CHF 0.10, nominatives.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006060514 ↗
  7. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    1’036’041.40 → 1’115’069.20
    Shares
    10’360’414 → 11’150’692
    New shares, % of post-step shares
    7.1% (790’278 new)

    Augmentation ordinaire du capital-actions porté de CHF 1'036'041, 4 à CHF 1'115'069, 2, soit d'un montant de CHF 79'027.80, par l'émission de 790'278 actions de CHF 0.10, nominatives. Capital-actions: CHF 1'115'069, 2, entièrement libéré, divisé en 11'150'692 actions de CHF 0.10, nominatives.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0

    Classifier score 0.70 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006438236 ↗

Published by 21 Sep 2025

Latest available record · 8 Oct 2026